Quarterly Statement Of Cash Flows

Mochida Pharmaceutical Co.,Ltd. - Filing #7323284

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-6,440,000,000 JPY
11,173,000,000 JPY
Interest and dividends received
365,000,000 JPY
340,000,000 JPY
Income taxes paid
-1,368,000,000 JPY
-3,224,000,000 JPY
Net cash provided by (used in) operating activities
-7,480,000,000 JPY
7,297,000,000 JPY
Cash flows from investing activities
Purchase of securities
-10,500,000,000 JPY
-10,500,000,000 JPY
Proceeds from sale of securities
10,500,000,000 JPY
10,500,000,000 JPY
Proceeds from sale of property, plant and equipment
56,000,000 JPY
0 JPY
Purchase of investment securities
-300,000,000 JPY
JPY
Proceeds from sale of investment securities
2,601,000,000 JPY
JPY
Other, net
11,000,000 JPY
316,000,000 JPY
Net cash provided by (used in) investing activities
74,000,000 JPY
-2,949,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-3,492,000,000 JPY
-3,512,000,000 JPY
Dividends paid
-2,887,000,000 JPY
-3,372,000,000 JPY
Other, net
-14,000,000 JPY
0 JPY
Net cash provided by (used in) financing activities
-6,393,000,000 JPY
-6,884,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
79,000,000 JPY
32,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-13,720,000,000 JPY
-2,504,000,000 JPY
Cash and cash equivalents
24,290,000,000 JPY
38,010,000,000 JPY
40,515,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.